Works matching IS 13520504 AND DT 2006 AND VI 13 AND IP 4

Results: 10

Efficacy of repeated high-dose hepatitis B vaccine (80 μg) in patients with chronic liver disease.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 217, doi. 10.1111/j.1365-2893.2005.00674.x

By:

Aziz, A.;
Aziz, S.;
Li, D. S.;
Murphy, L.;
Leone, N.;
Kennedy, M.;
Dhillon, S.;
Van Thiel, D. H.

Publication type:

Article

A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 222, doi. 10.1111/j.1365-2893.2005.00678.x

By:

Moghaddam, A.;
Reinton, N.;
Dalgard, O.

Publication type:

Article

Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 230, doi. 10.1111/j.1365-2893.2005.00679.x

By:

Marín-Serrano, E.;
Rodríguez-Ramos, C.;
Díaz, F.;
Martín-Herrera, L.;
Girón-González, J. A.

Publication type:

Article

Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 235, doi. 10.1111/j.1365-2893.2005.00681.x

By:

Chainuvati, S.;
Khalid, S. K.;
Kancir, S.;
Shea, M.;
Edwards, J.;
Sernyak, M.;
Wongcharatrawee, S.;
Garcia-Tsao, G.

Publication type:

Article

Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 242, doi. 10.1111/j.1365-2893.2005.00682.x

By:

Bräu, N.;
Bini, E. J.;
Currie, S.;
Shen, H.;
Schmidt, W. N.;
King, P. D.;
Ho, S. B.;
Cheung, R. C.;
Hu, K.-Q.;
Anand, B. S.;
Simon, F. R.;
Aytaman, A.;
Johnson, D. P.;
Awad, J. A.;
Ahmad, J.;
Mendenhall, C. L.;
Pedrosa, M. C.;
Moseley, R. H.;
Hagedorn, C. H.;
Waters, B.

Publication type:

Article

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 250, doi. 10.1111/j.1365-2893.2005.00687.x

By:

Liaw, Y.-F.;
Lee, C.-M.;
Chien, R.-N.;
Yeh, C.-T.

Publication type:

Article

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 256, doi. 10.1111/j.1365-2893.2005.00695.x

By:

Tillmann, H. L.;
Hadem, J.;
Leifeld, L.;
Zachou, K.;
Canbay, A.;
Eisenbach, C.;
Graziadei, I.;
Encke, J.;
Schmidt, H.;
Vogel, W.;
Schneider, A.;
Spengler, U.;
Gerken, G.;
Dalekos, G. N.;
Wedemeyer, H.;
Manns, M. P.

Publication type:

Article

Is hepatitis C virus a risk factor for thyroid autoimmunity?

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 272, doi. 10.1111/j.1365-2893.2005.00699.x

By:

Floreani, A.;
Betterle, C.;
Carderi, I.;
Presotto, F.;
Pedini, B.;
Moscon, A.;
Di Andrea, O.;
Chiaramonte, M.

Publication type:

Article

A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 278, doi. 10.1111/j.1365-2893.2005.00712.x

By:

Zoulim, F.;
Poynard, T.;
Degos, F.;
Slama, A.;
El Hasnaoui, A.;
Blin, P.;
Mercier, F.;
Deny, P.;
Landais, P.;
Parvaz, P.;
Trepo, C.

Publication type:

Article

Clinical pathways for patients with newly diagnosed hepatitis C – What actually happens.

Published in:

Journal of Viral Hepatitis, 2006, v. 13, n. 4, p. 264, doi. 10.1111/j.1365-2893.2005.00698.x

By:

Irving, W. L.;
Smith, S.;
Cater, R.;
Pugh, S.;
Neal, K. R.;
Coupland, C. A. C.;
Ryder, S. D.;
Thomson, B. J.;
Pringle, M.;
Bicknell, M.;
Hippisley-Cox, J.

Publication type:

Article